SNN Share Price

Open 35.94 Change Price %
High 35.98 1 Day 0.14 0.39
Low 35.76 1 Week -0.92 -2.50
Close 35.89 1 Month 0.25 0.70
Volume 250958 1 Year 2.54 7.62
52 Week High 37.22
52 Week Low 26.97
SNN Important Levels
Resistance 2 36.09
Resistance 1 36.01
Pivot 35.88
Support 1 35.77
Support 2 35.69
NYSE USA Most Active Stocks
RAI 65.40 -2.23%
RAI 65.40 -2.23%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
BAC 25.02 -0.56%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
QUAD 22.58 14.21%
ANW 4.65 13.41%
MSB 23.45 12.20%
MSB 23.45 12.20%
FNP 35.24 12.02%
FNP 35.24 12.02%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Smith & Nephew SNATS, Inc. (NYSE: SNN)

SNN Technical Analysis 4
As on 22nd Sep 2017 SNN Share Price closed @ 35.89 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 32.35 & Buy for SHORT-TERM with Stoploss of 35.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
SNN Target for September
1st Target up-side 37.22
2nd Target up-side 37.79
3rd Target up-side 38.36
1st Target down-side 35.58
2nd Target down-side 35.01
3rd Target down-side 34.44
SNN Other Details
Segment EQ
Market Capital 9844970496.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.smith-nephew.com
SNN Address
SNN
15 Adam Street
London, WC2N 6LA
United Kingdom
Phone: 44 20 7401 7646
Fax: 44 20 7930 3353
SNN Latest News
Interactive Technical Analysis Chart Smith & Nephew SNATS, Inc. ( SNN NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Smith & Nephew SNATS, Inc.
SNN Business Profile
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and trauma and extremities products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company’s Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. Smith & Nephew plc primarily serves medical and surgical treatments and service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.